🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
characterization of CFTR function and expression in nasal primary cells col...
Status
Completed
Location
Multiple Locations
Start Date
2010-09-01
Trial ID
NCT03652090
Treatments Being Tested
Pterygium is the growth of conjunctival tissue onto the cornea, usually fro...
Status
Unknown
Location
Zhongshan Opthalmic Center
Start Date
2017-11-01
Trial ID
NCT03406390
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
Start Date
2000-03
Trial ID
NCT00014456
Treatments Being Tested
The goal of this laboratory study is the examine the effect of mepolizumab ...
Status
Completed
Location
Johns Hopkins Bayview Medical Center
Start Date
2023-09-05
Trial ID
NCT05895929
Treatments Being Tested
The purpose of this study is to validate and utilize a personalized medicin...
Status
Recruiting
Location
CCHMC
Start Date
2021-05-01
Trial ID
NCT04580368
Treatments Being Tested
This study is designed to learn more about the impact different types of st...
Status
Suspended
Location
Tufts Medical Center
Start Date
2023-05-16
Trial ID
NCT05758753
Treatments Being Tested
Despite public campaigns to prevent cigarette smoking, it's about 20% of wo...
Status
Completed
Location
Inserm
Start Date
2017-11-10
Trial ID
NCT03047967
Treatments Being Tested
This study will serve to determine how influenza infection alters the bacte...
Status
Completed
Location
UCLA
Start Date
2011-02
Trial ID
NCT02597647
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Jonsson Comprehensive Cancer Center, UCLA
Start Date
1999-07
Trial ID
NCT00004065
Treatments Being Tested
RATIONALE: Suberoylanilide hydroxamic acid may stop the growth of cancer ce...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2001-07
Trial ID
NCT00045006
Treatments Being Tested